CDAK - Codiak BioSciences  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CDAK is currently covered by 1 analysts with an average price target of $2.36. This is a potential upside of $2.36 (0%) from yesterday's end of day stock price of $0.

Codiak BioSciences 's activity chart (see below) currently has 11 price targets and 9 ratings on display. The stock rating distribution of CDAK is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 8.5 days.

Highest price target for CDAK is $1, Lowest price target is $1, average price target is $2.36.

Most recent stock forecast was given by ANDREA TAN from GOLDMAN SACHS on 07-Nov-2022. First documented stock forecast 09-Nov-2020.

Best performing analysts who are covering CDAK - Codiak BioSciences :

David Nierengarten Andrea Tan

Currently out of the existing stock ratings of CDAK, 1 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$1.4

$1.39 (13900.00%)

$2

1 years 10 months 2 days ago

1/3 (33.33%)

$0.6 (75.00%)

1

Buy

$7

$6.99 (69900.00%)

$24

2 years 2 months 4 days ago

2/6 (33.33%)

$4.12 (143.06%)

16

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CDAK (Codiak BioSciences ) average time for price targets to be met?

On average it took 8.5 days on average for the stock forecasts to be realized with a an average price target met ratio 33.33

Which analyst has the current highest performing score on CDAK (Codiak BioSciences ) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the current lower performing score on CDAK (Codiak BioSciences ) with a proven track record?

ANDREA TAN

Which analyst has the most public recommendations on CDAK (Codiak BioSciences )?

David Nierengarten works at WEDBUSH and has 5 price targets and 4 ratings on CDAK

Which analyst is the currently most bullish on CDAK (Codiak BioSciences )?

David Nierengarten with highest potential upside - $6.99

Which analyst is the currently most reserved on CDAK (Codiak BioSciences )?

Andrea Tan with lowest potential downside - $1.39

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?